Company intelligence / Profile preview

Xhale Assurance

Gainesville, Florida, United States

Ownership: Private
Employees: ~50
Development stage: Commercial

Overview

The company developed a next-generation nasal alar pulse oximetry sensor capable of accurate heart rate and blood oxygenation measurement under low perfusion conditions. This device addressed limitations of conventional fingertip sensors and was commercialized prior to acquisition by Philips. No clinical trial results are specified; the product was marketed for enhanced patient safety in critical care settings.

Therapeutic areas: PulmonologyCardiovascular
Modalities: Device
Industry: Physiological Monitoring

Beyond the preview

Go deeper on Xhale Assurance.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Xhale Assurance.

Explore the full profile